Current Tendency of “Blood Coagulation (Clotting) Testing Market” – 2018 Synopsis | Future Perspective and Estimations up to 2023 Market Research Future published a research report on Global Blood Coagulation Testing Market and predicts that Global Blood Coagulation Testing Market is expected to grow at a healthy CAGR of 6.5% during the forecasted period and report include market Analysis, Scope, Stake, Progress, Trends and forecast till 2023. The liver plays an important role in the normal functioning of hemostasis, which helps in preventing bleeding and undue activation of coagulation. According to the Centers for Disease Control and Prevention (CDC), in 2015, around 3.9 million adults were diagnosed with liver disease, which is about 1.6% of adult population of the U.S. According to a study conducted by the Global Burden of Disease Liver Cancer Collaboration, in 2015, around 854,000 new incidents of liver cancer were found and 810,000 deaths occurred owing to liver cancer globally. Furthermore, it is the sixth most common-incident cancer globally and the fourth most common cause of cancer death. Moreover, advancing technology in blood coagulation testing is adding fuel to the growth of the market. Furthermore, increasing prevalence of liver disease, thrombophilia, and hemophilia also drives the market growth. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
The Global Blood Coagulation Testing Market is expected to grow at a CAGR of 6.5 % during the forecast period 2017-2023. Get Sample PDF Illustration https://www.marketresearchfuture.com/sample_request/970
@
Key Players for Global Blood Coagulation Testing Market Some of the major players for the global blood coagulation market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), Bio/Data Corporation (U.S.) Segments for Global Blood Coagulation Testing Market The global blood coagulation market is segmented on the basis of product, application, test type, and end user. On the basis of the product, the market is segmented into clinical laboratory, automated testing, and semi-automated testing. On the basis of application, the market is segmented into congenital bleeding disorders, acquired bleeding disorders, Von Willebrand disease, and hemophilia.